Earlier blood-test detection could help identify pancreatic cancer patients who need more aggressive treatment, an expert ...

Genomic Testing Cooperative (GTC) today highlighted its Liquid Trace® cerebrospinal fluid (CSF)-based molecular profiling ...

A panelist discusses how education and cost are key challenges in ensuring comprehensive molecular testing is performed in a timely manner for patients with ovarian cancer, emphasizing the need for ...

Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...

A panelist discusses how National Comprehensive Cancer Network (NCCN) guidelines have influenced molecular testing in ovarian cancer, highlighting the importance of biomarkers like BRCA genes for ...

Camryn was diagnosed with a low-grade glioma at age two after her parents noticed a lazy eye. Sixteen years, 11 brain surgeries and over six years of chemotherapy treatment, Camryn is now ...

Brain tumors have long forced pathologists into a difficult balancing act. Under the microscope, many look alike at first glance.

Imagine diagnosing cancer, tracking its progress, and identifying treatment resistance—all from a simple blood sample. Just a decade ago, this sounded like science fiction. Today, it is becoming an ...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that its Oncodetect™ molecular residual disease (MRD) ...

Targeted compound daraxonrasib successfully blocks multiple KRAS variants to double survival limits in clinical trials.

Bengaluru doctors have successfully treated a 68-year-old man diagnosed with metastatic, Stage 4 gastric adenocarcinoma, ...

Hearing that two people have the same type of cancer often leads to one assumption: they'll receive the same treatment. However, modern oncology has moved fa ...